Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Call for expressions of interest for rapid-access COVID-19 related research opportunities

The European X-Ray Free-Electron Laser Facility (European XFEL) would like to offer support to the global campaign against the novel Coronavirus, SARS-CoV-2, by offering specific and rapid access to the resources of the facility for this purpose.

The call for expressions of interest in rapid access to European XFEL research resources closed on 17 June 2020. Expressions of interest received after the deadline will still be considered on an ongoing basis, however, rapid access to beamtime cannot be guaranteed.


A dedicated online information meeting, hosted by the European XFEL User Organization, took place on 09 June 2020. More information about the event is posted here

In this specific framework, possible research options include:

  • The X-ray instruments of European XFEL can be used to address biology, chemistry and materials science questions associated with the novel coronavirus, SARS-CoV-2, and related treatment, diagnostics and infection prevention. 
    Beamtime will be reserved for rapid access to selected COVID-19 related research projects in the second half of 2020. 
    More information on research at all European XFEL scientific instruments, addressing additional scientific areas, such as femtochemistry, investigations of atoms, molecules, clusters and gas-phase chemistry, hard and soft condensed matter is available here.
  • The European XFEL user laboratories offer unique possibilities in terms of protein production, crystallization, sample preparation and quality control in biology, chemistry and material science. Information on available facilities can be accessed through this link.
  • Data analysis services are available for crystallography data.
  • Know-how on nano- and micro-crystal delivery for experiments with XFEL beams in order to reduce consumption of sample as well as enabling work towards different mixing conditions.

Samples containing active viruses cannot currently be examined at European XFEL.

All expressions of interest will be considered and followed up.

Expressions of interest received after the deadline of 17 June 2020 will still be considered on an ongoing basis, however, rapid access to beamtime cannot be guaranteed.

Please provide your contact data and fill in the form below to state your interest in access to European XFEL research resources by providing a short description of your project and research interests.
(This question is mandatory)
First name
(This question is mandatory)
Last name
(This question is mandatory)
Email Address
(This question is mandatory)
e.g. “European XFEL”
(This question is mandatory)
Please provide a short title for your expression of interest
(This question is mandatory)
Scientific area
(This question is mandatory)
Please provide a short description of your research and your project. 
Please specify in this section which resources are requested from European XFEL (scientific instruments, user laboratory access, data analysis support, sample environment / nano- and micro-crystal delivery support…)
(This question is mandatory)

Samples availability and preparation

Please state the estimated date of availability of your Samples or how long the preparation may take
(This question is mandatory)

On-site presence

Does your project require your presence on the European XFEL site?
(This question is mandatory)

Why does your project require rapid access?

Please note any additional comments or special requests in the field below.
(This question is mandatory)
Privacy Notice

Inquiries can be addressed to Sakura Pascarelli (, scientific director for hard X-ray instruments, Serguei Molodtsov (, scientific director for soft X-ray instruments and Sample Environment and Characterization, or Adrian Mancuso (, leading scientist for the SPB/SFX instrument.

For technical support regarding the call, please contact